Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Abstract IA010: Bioengineering cell-based therapeutics
View through CrossRef
Abstract
Cell-based therapeutics are an emerging modality that can potentially treat many currently intractable diseases through uniquely powerful modes of action. Our group is innovating new biomaterials and cellular constructs for medicine and biology by combining chemical biology, cellular engineering, and multi-scale fabrication. We have pioneered innovative approaches to synthesizing and in vivo screening of large libraries of biomaterial formulations for tailored applications in immunology and medicine. In my talk, I will describe our advances in discovering immunomodulatory biomaterials that can interact appropriately with the host immune system for localized immunomodulation. I will highlight our efforts to develop “cytokine factories” locally activating the innate and adaptive immune response to generate systemic immunotherapy and eradicate metastatic cancer. This approach has advanced to phase I/II human clinical trials for treating recurrent, refractory ovarian cancer.
Citation Format: Omid Veiseh. Bioengineering cell-based therapeutics [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Optimizing Therapeutic Efficacy and Tolerability through Cancer Chemistry; 2024 Dec 9-11; Toronto, Ontario, Canada. Philadelphia (PA): AACR; Mol Cancer Ther 2024;23(12_Suppl):Abstract nr IA010.
Title: Abstract IA010: Bioengineering cell-based therapeutics
Description:
Abstract
Cell-based therapeutics are an emerging modality that can potentially treat many currently intractable diseases through uniquely powerful modes of action.
Our group is innovating new biomaterials and cellular constructs for medicine and biology by combining chemical biology, cellular engineering, and multi-scale fabrication.
We have pioneered innovative approaches to synthesizing and in vivo screening of large libraries of biomaterial formulations for tailored applications in immunology and medicine.
In my talk, I will describe our advances in discovering immunomodulatory biomaterials that can interact appropriately with the host immune system for localized immunomodulation.
I will highlight our efforts to develop “cytokine factories” locally activating the innate and adaptive immune response to generate systemic immunotherapy and eradicate metastatic cancer.
This approach has advanced to phase I/II human clinical trials for treating recurrent, refractory ovarian cancer.
Citation Format: Omid Veiseh.
Bioengineering cell-based therapeutics [abstract].
In: Proceedings of the AACR Special Conference in Cancer Research: Optimizing Therapeutic Efficacy and Tolerability through Cancer Chemistry; 2024 Dec 9-11; Toronto, Ontario, Canada.
Philadelphia (PA): AACR; Mol Cancer Ther 2024;23(12_Suppl):Abstract nr IA010.
Related Results
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
Human tissues comprise trillions of cells that populate a complex space of molecular phenotypes and functions and that vary in abundance by 4–9 orders of magnitude. Relying solely ...
Abstract IA010: Engineering human sialidase as novel cancer therapeutics by targeting sialoglycans
Abstract IA010: Engineering human sialidase as novel cancer therapeutics by targeting sialoglycans
Abstract
Immune checkpoint blockade has revolutionized cancer treatment, but resistance remains a significant hurdle for many patients. Sialoglycans, as new immune c...
T-Cell Engineering For “off-The-shelf” Adoptive Immunotherapy
T-Cell Engineering For “off-The-shelf” Adoptive Immunotherapy
Abstract
Adoptive T-cell therapies, where exogenous expression of a chimeric antigen receptor (CAR) confers cancer recognition, have shown significant promise in ini...
Stem cells
Stem cells
What is a stem cell? The term is a combination of ‘cell’ and ‘stem’. A cell is a major category of living thing, while a stem is a site of growth and support for something else. In...
Implications of differential size-scaling of cell-cycle regulators on cell size homeostasis
Implications of differential size-scaling of cell-cycle regulators on cell size homeostasis
AbstractAccurate timing of division and size homeostasis is crucial for cells. A potential mechanism for cells to decide the timing of division is the differential scaling of regul...
Global Research Trends on Digital therapeutics in Early 21st Century: A Data-driven Bibliometric Analysis (Preprint)
Global Research Trends on Digital therapeutics in Early 21st Century: A Data-driven Bibliometric Analysis (Preprint)
UNSTRUCTURED
As an emerging therapeutics plan, digital therapeutics has attracted increasing attention in recent years, with numerous research hotspots cont...
Abstract 1760: Single cell longitudinal studies reveal cell cycle specific effects of selective inhibitors of nuclear export (SINE)
Abstract 1760: Single cell longitudinal studies reveal cell cycle specific effects of selective inhibitors of nuclear export (SINE)
Abstract
Nuclear export of proteins is fundamental for cell growth and function. Selinexor is a SINE compound that is in clinical development for the treatment of di...